共 48 条
- [31] Fabrication of zeolite-supported cobalt ferrite (CoFe2O4/ H-zsm-5) catalyst for the synthesis of 4-(9-(4-substituted)-1,2,3,4,5,6,7,8-octahydro-3,3,6,6-tetramethyl-1,8-dioxoacridin-10(9H)-yl)benzoic acid derivatives in semi aqueous condition [J]. JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS, 2024, 193
- [32] Crystal structure of (1S,3S,6S,7S,8S,9R)-7-acetoxy-9-hydroxy 6-(4-methoxybenzyl)-3-[N-methyl-N-(4-methylphenyl)sulfonylamino]-5-azatricyclo[6.3.1.01.5]dodecan-4-one, C29H36N2O7S [J]. ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2000, 215 (04): : 597 - 599
- [34] Green synthesis of (E)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a] phenanthren-3-yl 6-(4-(3-(4-methoxyphenyl)acryloyl)phenoxy)hexanoate [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
- [35] The crystal structure of 3,4-dihydroxybenzoic acid-3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol - water (1/1/1), C30H36F2N6O9S [J]. ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, 238 (02): : 331 - 333
- [38] Bioorganometallic chemistry Part 12.: Reaction of [Cp*Rh(H2O)3](OTf)2 with nicotinamide adenine dinucleotide in water:: synthesis, structure, and a pH-dependent 1H-NMR and voltammetric study of the cyclic trimer product, [Cp*Rh(μ-η1(N1):η2(N6,N7)-9-(5′-ribose pyrophosphate-5"-ribose-1"-nicotinamide)adeninato]3(OTf)3 [J]. JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1999, 589 (01) : 66 - 74
- [39] Induction of nitric oxide production by the cytostatic macrolide apicularen A [2,4-heptadienamide, N-[(1E)-3-[(3S,5R,7R,9S)-3,4,5,6,7,8,9,10-octahydro-7,14 dihydroxy-1-oxo-5,9-epoxy-1H-2-benzoxacyclododecin-3-yl]-1 propenyl]-, (2Z,4Z)-(9CI)] and possible role of nitric oxide in apicularen A-induced apoptosis in RAW 264.7 cells [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03): : 968 - 977
- [40] Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2 [J]. ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (03): : 411 - 413